Nigel Mccracken

1 Patent

• US121448182024

  Method for Treating Cancer in a Human Patient by Administering an Anti-cd37 Immunoconjugate Using Various Dosing Regimens

  DEBIOPHARM INTERNATIONAL, S.A.

  0 cites